• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Perindopril Erbumine

Perindopril Erbumine

Product ID P1869
Cas No. 107133-36-8
Purity ≥95%
Product Unit SizeCostQuantityStock
100 mg $112.60 In stock
250 mg $225.30 In stock
1 g $662.10 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Perindopril exhibits antihypertensive, anti-fibrotic, neuroprotective, cognition enhancing, anticancer chemotherapeutic, and chemopreventive activities. Perindopril is an angiotensin-converting enzyme (ACE) inhibitor that decreases blood pressure, vascular resistance, and vasoconstriction in animal models and in clinical settings. Perindopril also increases extracellular acetylcholine (ACh) and ameliorates cognitive impairment in animal models of vascular dementia and Alzheimer’s disease. In other animal models, perindopril decreases activity of NF-κB and levels of AT1R, TGF-β1, PDGF-BB, laminin, and hyaluronic acid, decreasing hepatic fibrosis. Perindopril displays both pro-angiogenic and anti-angiogenic activities depending on the animal models. In diabetic animal models of hind limb ischemia, perindopril increases expression of eNOS, VEGF, bFGF and BO, increasing capillary density and post-ischemic revascularization. In animal models of hepatocellular carcinoma, this compound inhibits VEGF expression and tubule formation, preventing angiogenesis and tumor development.

Product Info

Cas No.

107133-36-8

Purity

≥95%

Formula

C19H32N2O5 • C4H11N

Formula Wt.

441.60

IUPAC Name

(2S,3aS, 7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a, 4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine

Melting Point

100-101°C

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P1869 MSDS PDF

Info Sheet

P1869 Info Sheet PDF

References

Yamada K, Horita T, Takayama M, et al. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats. Brain Res. 2011 Nov 3;1421:110-20. PMID: 21981801.

Gao L, Yu DM. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats. Chin Med J (Engl). 2008 Nov 5;121(21):2129-33. PMID: 19080171.

Li X, Meng Y, Yang XS, et al. ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9. World J Gastroenterol. 2005 Aug 21;11(31):4807-11. PMID: 16097048.

Yoshiji H, Kuriyama S, Kawata M, et al. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res. 2001 Apr;7(4):1073-8. PMID: 11309359.

Richer C, Doussau MP, Giudicelli JF. Perindopril, a new converting enzyme inhibitor: systemic and regional hemodynamics and sympathoinhibitory effects in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1986 Mar-Apr;8(2):346-57. PMID: 2422474.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • E6235

    Epirubicin Hydrochloride

    Anthracycline, DNA intercalator; topoisomerase ...

    ≥90%
  • O6845

    Orlistat

    Fatty acid synthase inhibitor.

    ≥98%
  • P0146

    Palmitoyl-L-carnitine

    Long chain acylcarnitine involved in fatty acid...

    ≥98%
  • W0247

    Walrycin B

    Walrycin response regulator inhibitor.

    ≥98%
  • E5222

    Endothelin-3, human

    Endogenous peptide, involved in vascular contra...

    ≥95%
  • D5869

    Doripenem Hydrate

    β-lactam carbapenem; penicillin binding protei...

    ≥99%
  • C2944

    Chlorogenic Acid (from Lonicera)

    Polyphenol derivative of caffeic acid found in ...

    ≥99%
  • D760022

    DT-2216

    BCL-XL specific degrader

    ≥98%
  • A4931

    3-Aminobenzamide

    PARP inhibitor.

    ≥97%
  • C9809

    Cyclopiazonic Acid

    SERCA inhibitor.

    ≥98%, TLC
  • D582703

    Dorsomorphin

    Inhibitor of ALK2, ALK3, ALK6, and AMPK.

    ≥98%
  • P004080

    PAC-1

    Zinc chelator

    ≥98%
  • L589938

    LOXO-195

    Inhibitor of TRK.

    ≥99%
  • O4402

    Olaparib

    PARP1/2 inhibitor.

    ≥98%
  • B3300

    BI-6727

    PLK1 inhibitor.

    ≥99%
  • P6858

    Procarbazine Hydrochloride

    Hydrazine derivative, DNA alkylator; MAO inhibi...

    ≥97%
  • I7458

    1-Isothiocyanato-9-(methylsulfinyl)-nonane

    ITC, sulforaphane analog.

    ≥98%
  • S7769

    Streptomycin Sulfate

    Aminoglycoside; protein translation inhibitor, ...

    ≥98%
  • M9643

    Myelin Basic Protein (1-11), human

    Peptide antigen fragment

    ≥95%
  • Z161024

    α-Zearalenol

    Mycotoxin that has structural similarity to est...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only